{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:58:03Z","timestamp":1772121483438,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ophtha.2010.03.049","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T05:21:42Z","timestamp":1277875302000},"page":"2424-2429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Topical Imiquimod for Periocular Lentigo Maligna"],"prefix":"10.1016","volume":"117","author":[{"given":"Hakan","family":"Demirci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos G.","family":"Bianciotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry A.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2010.03.049_bib1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0190-9622(95)90282-1","article-title":"Lentigo maligna and lentigo maligna melanoma","volume":"33","author":"Cohen","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5694\/j.1326-5377.1980.tb134628.x","article-title":"Changing epidemiology of malignant melanoma in Queensland","volume":"1","author":"Little","year":"1980","journal-title":"Med J Aust"},{"key":"10.1016\/j.ophtha.2010.03.049_bib3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0025-6196(12)62140-5","article-title":"Cutaneous malignant melanoma in Rochester, Minnesota: trends in incidence and survivorship, 1950 through 1985","volume":"65","author":"Pospescu","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ophtha.2010.03.049_bib4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9610(72)90065-7","article-title":"Clinicopathologic study of cutaneous melanoma of the head and neck","volume":"124","author":"Donnellan","year":"1972","journal-title":"Am J Surg"},{"key":"10.1016\/j.ophtha.2010.03.049_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0046-8177(99)90197-1","article-title":"Lentigo maligna and malignant melanoma in situ, lentigo maligna type","volume":"30","author":"Flotte","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/hupa.2000.7640","article-title":"Progression to invasive melanoma from melanoma in situ, lentigo maligna type","volume":"31","author":"Tannous","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jso.20081","article-title":"Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology","volume":"86","author":"Arlette","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0161-6420(02)00962-4","article-title":"Clinicopathologic features and behavior of cutaneous eyelid melanoma","volume":"109","author":"Vaziri","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.03.049_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.IOP.0000056141.97930.E8","article-title":"Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group report","volume":"19","author":"Esmaeli","year":"2003","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ophtha.2010.03.049_bib10","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.ophtha.2008.06.011","article-title":"Management of periocular cutaneous melanoma with a staged excision technique and permanent sections: the square procedure","volume":"115","author":"Demirci","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.03.049_bib11","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/archderm.139.10.1347","article-title":"Imiquimod: a topically applied link between innate and acquired immunity","volume":"139","author":"Hurwitz","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D34VW339W4","article-title":"Imiquimod 5 percent cream and the treatment of cutaneous malignancy","volume":"10","author":"Navi","year":"2004","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ophtha.2010.03.049_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1067\/mjd.2002.126215","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study","volume":"47","author":"Geisse","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archderm.138.9.1165","article-title":"Efficacy of topical 5% imiquimod cream for the treatment of superficial and nodular basal cell carcinoma: comparison of dosing regimens","volume":"138","author":"Shumack","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1067\/mjd.2001.111335","article-title":"Imiquimod 5% in the treatment of Bowen's disease","volume":"44","author":"Mackenzie-Wood","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib16","first-page":"555","article-title":"Topical imiquimod treatment of a cutaneous melanoma metastasis","volume":"43","author":"Steinmann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.0366-077X.2003.05637.x","article-title":"Treatment of lentigo maligna with topical imiquimod","volume":"149","author":"Naylor","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2133.2006.07476.x","article-title":"Imiquimod in the treatment of lentigo maligna","volume":"155","author":"Rajpar","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archderm.141.4.510","article-title":"Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod","volume":"141","author":"Wolf","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2133.2004.05983.x","article-title":"A pilot study of treatment of lentigo maligna with 5% imiquimod cream","volume":"151","author":"Fleming","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1440-0960.2006.00313.x","article-title":"Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks","volume":"47","author":"Quirk","year":"2006","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaad.2006.05.030","article-title":"Imiquimod for the treatment of actinic keratosis: a meta-analysis of randomized controlled trials","volume":"55","author":"Falagas","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/dtb.2009.09.0040","article-title":"Imiquimod for superficial and in situ skin malignancy","volume":"47","year":"2009","journal-title":"Drug Ther Bull"},{"key":"10.1016\/j.ophtha.2010.03.049_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jaad.2009.08.023","article-title":"Imiquimod use in the treatment of lentigo maligna","volume":"61","author":"Junkins-Hopkins","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2230.2002.01151.x","article-title":"Imiquimod and the imidazoquinolones; mechanism of action and therapeutic potential","volume":"27","author":"Stanley","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.0366-077X.2003.05634.x","article-title":"Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle","volume":"149","author":"Berman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib28","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/djg016","article-title":"Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod","volume":"95","author":"Schon","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ophtha.2010.03.049_bib29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1046\/j.1365-2133.2000.03787.x","article-title":"Imiquimod: a novel treatment for lentigo maligna","volume":"143","author":"Ahmed","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1524-4725.2007.34031.x","article-title":"Treatment of lentigo maligna with imiquimod before staged excision","volume":"34","author":"Cotter","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ophtha.2010.03.049_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2230.2004.01452.x","article-title":"Topical imiquimod immunotherapy in the management of lentigo maligna","volume":"29","author":"Powell","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib32","first-page":"623","article-title":"Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream","volume":"33","author":"van Meurs","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ophtha.2010.03.049_bib33","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0161-6420(03)00670-5","article-title":"Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma","volume":"110","author":"Malhotra","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2010.03.049_bib34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archderm.139.7.945","article-title":"Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease [letter]","volume":"139","author":"Fisher","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2010.03.049_bib35","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1524-4725.2009.01227.x","article-title":"Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod","volume":"35","author":"Woodmansee","year":"2009","journal-title":"Dermatol Surg"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642010003283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642010003283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:00:41Z","timestamp":1758981641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642010003283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0161642010003283"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.03.049","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.9582973.10243075","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Imiquimod for Periocular Lentigo Maligna","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}